|
|
|
|
|
1
|
A bill to be entitled |
|
2
|
An act relating to a public records exemption for |
|
3
|
proprietary confidential business information owned or |
|
4
|
controlled by the H. Lee Moffitt Cancer Center and |
|
5
|
Research Institute; amending s. 1004.43, F.S.; revising |
|
6
|
the exemption for proprietary confidential business |
|
7
|
information owned or controlled by the not-for-profit |
|
8
|
corporation which governs and operates the H. Lee Moffitt |
|
9
|
Cancer Center and Research Institute or subsidiaries of |
|
10
|
the corporation to include specified materials, potential |
|
11
|
trade secrets, potentially patentable material, actual |
|
12
|
trade secrets, business transactions, or proprietary |
|
13
|
information received, generated, ascertained, or |
|
14
|
discovered during the course of research conducted within |
|
15
|
state universities that are exempt from public records |
|
16
|
requirements under s. 1004.22(2), F.S.; providing for |
|
17
|
future review and repeal of the exemption; providing a |
|
18
|
statement of public necessity; providing an effective |
|
19
|
date. |
|
20
|
|
|
21
|
Be It Enacted by the Legislature of the State of Florida: |
|
22
|
|
|
23
|
Section 1. Paragraph (b) of subsection (8) of section |
|
24
|
1004.43, Florida Statutes, is amended to read: |
|
25
|
1004.43 H. Lee Moffitt Cancer Center and Research |
|
26
|
Institute.--There is established the H. Lee Moffitt Cancer |
|
27
|
Center and Research Institute at the University of South |
|
28
|
Florida. |
|
29
|
(8) |
|
30
|
(b) Proprietary confidential business information is |
|
31
|
confidential and exempt from the provisions of s. 119.07(1) and |
|
32
|
s. 24(a), Art. I of the State Constitution. However, the Auditor |
|
33
|
General, the Office of Program Policy Analysis and Government |
|
34
|
Accountability, and the State Board of Education, pursuant to |
|
35
|
their oversight and auditing functions, must be given access to |
|
36
|
all proprietary confidential business information upon request |
|
37
|
and without subpoena and must maintain the confidentiality of |
|
38
|
information so received. As used in this paragraph, the term |
|
39
|
"proprietary confidential business information" means |
|
40
|
information, regardless of its form or characteristics, which is |
|
41
|
owned or controlled by the not-for-profit corporation or its |
|
42
|
subsidiaries; is intended to be and is treated by the not-for- |
|
43
|
profit corporation or its subsidiaries as private and the |
|
44
|
disclosure of which would harm the business operations of the |
|
45
|
not-for-profit corporation or its subsidiaries; has not been |
|
46
|
intentionally disclosed by the corporation or its subsidiaries |
|
47
|
unless pursuant to law, an order of a court or administrative |
|
48
|
body, a legislative proceeding pursuant to s. 5, Art. III of the |
|
49
|
State Constitution, or a private agreement that provides that |
|
50
|
the information may be released to the public; and which is |
|
51
|
information concerning: |
|
52
|
1. Internal auditing controls and reports of internal |
|
53
|
auditors; |
|
54
|
2. Matters reasonably encompassed in privileged attorney- |
|
55
|
client communications; |
|
56
|
3. Contracts for managed-care arrangements, including |
|
57
|
preferred provider organization contracts, health maintenance |
|
58
|
organization contracts, and exclusive provider organization |
|
59
|
contracts, and any documents directly relating to the |
|
60
|
negotiation, performance, and implementation of any such |
|
61
|
contracts for managed-care arrangements; |
|
62
|
4. Bids or other contractual data, banking records, and |
|
63
|
credit agreements the disclosure of which would impair the |
|
64
|
efforts of the not-for-profit corporation or its subsidiaries to |
|
65
|
contract for goods or services on favorable terms; |
|
66
|
5. Information relating to private contractual data, the |
|
67
|
disclosure of which would impair the competitive interest of the |
|
68
|
provider of the information; |
|
69
|
6. Corporate officer and employee personnel information; |
|
70
|
7. Information relating to the proceedings and records of |
|
71
|
credentialing panels and committees and of the governing board |
|
72
|
of the not-for-profit corporation or its subsidiaries relating |
|
73
|
to credentialing; |
|
74
|
8. Minutes of meetings of the governing board of the not- |
|
75
|
for-profit corporation and its subsidiaries, except minutes of |
|
76
|
meetings open to the public pursuant to subsection (9); |
|
77
|
9. Information that reveals plans for marketing services |
|
78
|
that the corporation or its subsidiaries reasonably expect to be |
|
79
|
provided by competitors; |
|
80
|
10. Trade secrets as defined in s. 688.002, including |
|
81
|
reimbursement methodologies or rates;or |
|
82
|
11. The identity of donors or prospective donors of |
|
83
|
property who wish to remain anonymous or any information |
|
84
|
identifying such donors or prospective donors. The anonymity of |
|
85
|
these donors or prospective donors must be maintained in the |
|
86
|
auditor's report; or. |
|
87
|
12. Materials and information exempted under s. |
|
88
|
1004.22(2). This subparagraph is subject to the Open Government |
|
89
|
Sunset Review Act of 1995 in accordance with s. 119.15 and shall |
|
90
|
stand repealed on October 2, 2008, unless reviewed and saved |
|
91
|
from repeal through reenactment by the Legislature. |
|
92
|
|
|
93
|
As used in this paragraph, the term "managed care" means systems |
|
94
|
or techniques generally used by third-party payors or their |
|
95
|
agents to affect access to and control payment for health care |
|
96
|
services. Managed-care techniques most often include one or more |
|
97
|
of the following: prior, concurrent, and retrospective review of |
|
98
|
the medical necessity and appropriateness of services or site of |
|
99
|
services; contracts with selected health care providers; |
|
100
|
financial incentives or disincentives related to the use of |
|
101
|
specific providers, services, or service sites; controlled |
|
102
|
access to and coordination of services by a case manager; and |
|
103
|
payor efforts to identify treatment alternatives and modify |
|
104
|
benefit restrictions for high-cost patient care. |
|
105
|
Section 2.(1) In 1995, the Legislature, in its |
|
106
|
discretion as expressed in chapter 95-263, Laws of Florida, made |
|
107
|
the not-for-profit corporation organized solely for the purpose |
|
108
|
of governing and operating the H. Lee Moffitt Cancer Center and |
|
109
|
Research Institute and its subsidiaries subject to the public |
|
110
|
records requirements of s. 119.07(1), Florida Statutes, and the |
|
111
|
open meeting requirements of s. 286.011, Florida Statutes. The |
|
112
|
provisions of chapter 95-263, Laws of Florida, currently |
|
113
|
expressed in s. 1004.43, Florida Statutes, exempted from the |
|
114
|
public records requirements of the not-for-profit corporation |
|
115
|
trade secrets as defined in s. 688.002, Florida Statutes, owned |
|
116
|
or controlled by the not-for-profit corporation or its |
|
117
|
subsidiaries. "Trade secret" which is broadly defined in s. |
|
118
|
688.002, Florida Statutes, includes a "device, method, |
|
119
|
technique, or process" that "derives economic value, actual or |
|
120
|
potential, from not being generally known." As the not-for- |
|
121
|
profit corporation's research activities have grown, the not- |
|
122
|
for-profit corporation has enjoyed significant coordination and |
|
123
|
joint development of research with the University of South |
|
124
|
Florida Division of Sponsored Research. The public records |
|
125
|
exemption for divisions of sponsored research at state |
|
126
|
universities contained in s. 1004.22(2), Florida Statutes, which |
|
127
|
applies to the Division of Sponsored Research at the University |
|
128
|
of South Florida, is different than the exemption in s. |
|
129
|
1004.43(8), Florida Statutes, for the H. Lee Moffitt Cancer |
|
130
|
Center and Research Institute, and this has led to confusion |
|
131
|
over the scope of protection of intellectual property enjoyed by |
|
132
|
the Division of Sponsored Research and the not-for-profit |
|
133
|
corporation. Conforming the public records exemption in s. |
|
134
|
1004.43(8), Florida Statutes, with the exemption in s. |
|
135
|
1004.22(2), Florida Statutes, will eliminate this confusion and |
|
136
|
allow the not-for-profit corporation to fulfill the institute's |
|
137
|
mission in the area of cancer research. |
|
138
|
(2) In the event that the public records exemption in s. |
|
139
|
1004.22(2), Florida Statutes, is determined to be broader than |
|
140
|
the public records exemption in s. 1004.43(8), Florida Statutes, |
|
141
|
a statement of public necessity would be appropriate. Because |
|
142
|
of the high incidence of cancer in the state, the Legislature |
|
143
|
recognizes the public need among the citizens of the state for |
|
144
|
access to the services provided by the H. Lee Moffitt Cancer |
|
145
|
Center and Research Institute, the public need for rapid |
|
146
|
advances in cancer prevention, treatments, and cures through |
|
147
|
medical research, and the public need for the not-for-profit |
|
148
|
corporation and its subsidiaries that operate the institute to |
|
149
|
be allowed the maximum degree of flexibility possible to fulfill |
|
150
|
the institute's mission in cancer treatment, research, and |
|
151
|
education. The Legislature finds that a public-sector and |
|
152
|
private-sector partnership between the state and the not-for- |
|
153
|
profit corporation and its subsidiaries is essential to fulfill |
|
154
|
the institute's mission. The Legislature further finds that the |
|
155
|
not-for-profit corporation and its subsidiaries must compete |
|
156
|
directly with their private-sector counterparts and that their |
|
157
|
economic survival depends on their ability to so compete. It is |
|
158
|
the intent of the Legislature that the not-for-profit |
|
159
|
corporation and its subsidiaries not be at a disadvantage in the |
|
160
|
competitive health care and medical research environment. |
|
161
|
(3) The Legislature finds that it is a public necessity |
|
162
|
that certain records of the not-for-profit corporation which |
|
163
|
governs and operates the H. Lee Moffitt Cancer Center and |
|
164
|
Research Institute and its subsidiaries, which contain |
|
165
|
proprietary confidential business information, including |
|
166
|
materials that relate to methods of manufacture or production, |
|
167
|
potential trade secrets, potentially patentable material, actual |
|
168
|
trade secrets, business transactions, or proprietary information |
|
169
|
received, generated, ascertained, or discovered during the |
|
170
|
course of research conducted at the institute or by the not-for- |
|
171
|
profit corporation or its subsidiaries be confidential and |
|
172
|
exempt from disclosure in the same manner as provided in s. |
|
173
|
1004.22(2), Florida Statutes. This exemption is necessary, to |
|
174
|
the extent that the exemption in s. 1004.22(2), Florida |
|
175
|
Statutes, is broader than the exemption in s. 1004.43(8), |
|
176
|
Florida Statutes, because the records contain information that, |
|
177
|
if disclosed, would adversely impact the not-for-profit |
|
178
|
corporation or its subsidiaries in the competitive health care |
|
179
|
and medical research environment. The highly confidential |
|
180
|
nature of cancer-related research discoveries necessitates that |
|
181
|
the not-for-profit corporation and its subsidiaries continue to |
|
182
|
be authorized to maintain confidential information it receives |
|
183
|
from, or generates for, the sponsors of its research. Without |
|
184
|
the exemption from public records requirements provided by |
|
185
|
section 1 of this act, the potential for the disclosure of |
|
186
|
confidential information would place the not-for-profit |
|
187
|
corporation and its subsidiaries on an unequal footing in the |
|
188
|
marketplace as compared with its private health care and medical |
|
189
|
research competitors that are not required to disclose such |
|
190
|
proprietary and confidential information. The Legislature finds |
|
191
|
that disclosure of such proprietary and confidential information |
|
192
|
would effectively prevent the not-for-profit corporation and its |
|
193
|
subsidiaries from expeditiously fulfilling the institute's |
|
194
|
mission of cancer treatment, research, and education. |
|
195
|
Section 3. This act shall take effect upon becoming a law. |
|
196
|
|